Nothing Special   »   [go: up one dir, main page]

NO20014529D0 - Tetrahydropyranderivater og deres anvendelse som terapautiske midler - Google Patents

Tetrahydropyranderivater og deres anvendelse som terapautiske midler

Info

Publication number
NO20014529D0
NO20014529D0 NO20014529A NO20014529A NO20014529D0 NO 20014529 D0 NO20014529 D0 NO 20014529D0 NO 20014529 A NO20014529 A NO 20014529A NO 20014529 A NO20014529 A NO 20014529A NO 20014529 D0 NO20014529 D0 NO 20014529D0
Authority
NO
Norway
Prior art keywords
therapeutic agents
tetrahydropyran derivatives
compounds
tetrahydropyran
derivatives
Prior art date
Application number
NO20014529A
Other languages
English (en)
Other versions
NO20014529L (no
Inventor
Simon Neil Owen
Eileen Mary Seward
Christopher John Swain
Brian John Williams
Original Assignee
Merck Sharp & Dohme
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9906480.0A external-priority patent/GB9906480D0/en
Priority claimed from GBGB9924616.7A external-priority patent/GB9924616D0/en
Application filed by Merck Sharp & Dohme filed Critical Merck Sharp & Dohme
Publication of NO20014529D0 publication Critical patent/NO20014529D0/no
Publication of NO20014529L publication Critical patent/NO20014529L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
NO20014529A 1999-03-19 2001-09-18 Tetrahydropyranderivater og deres anvendelse som terapautiske midler NO20014529L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9906480.0A GB9906480D0 (en) 1999-03-19 1999-03-19 Therapeutic agents
GBGB9924616.7A GB9924616D0 (en) 1999-10-18 1999-10-18 Therapeutic agents
PCT/GB2000/000977 WO2000056728A1 (en) 1999-03-19 2000-03-16 Tetrahydropyran derivatives and their use as therapeutic agents

Publications (2)

Publication Number Publication Date
NO20014529D0 true NO20014529D0 (no) 2001-09-18
NO20014529L NO20014529L (no) 2001-11-13

Family

ID=26315315

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20014529A NO20014529L (no) 1999-03-19 2001-09-18 Tetrahydropyranderivater og deres anvendelse som terapautiske midler

Country Status (23)

Country Link
US (1) US6458830B1 (no)
EP (1) EP1165540B1 (no)
JP (1) JP2002540107A (no)
KR (1) KR20010113773A (no)
CN (1) CN1344264A (no)
AT (1) ATE247096T1 (no)
AU (2) AU746251B2 (no)
BG (1) BG105859A (no)
BR (1) BR0009127A (no)
CA (1) CA2367985A1 (no)
CO (1) CO5150225A1 (no)
CZ (1) CZ20013377A3 (no)
DE (1) DE60004504T2 (no)
EA (1) EA200100902A1 (no)
EE (1) EE200100491A (no)
ES (1) ES2203434T3 (no)
HU (1) HUP0200441A3 (no)
IL (1) IL144236A0 (no)
NO (1) NO20014529L (no)
PE (1) PE20001556A1 (no)
PL (1) PL350123A1 (no)
SK (1) SK13322001A3 (no)
WO (2) WO2000056727A1 (no)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10001785A1 (de) * 2000-01-18 2001-07-19 Boehringer Ingelheim Pharma NK¶1¶-Rezeptor-Antagonisten zur Behandlung des Restless Legs Syndroms
GB0017256D0 (en) 2000-07-13 2000-08-30 Merck Sharp & Dohme Therapeutic agents
GB0020721D0 (en) 2000-08-22 2000-10-11 Merck Sharp & Dohme Therapeutic agents
PE20020444A1 (es) 2000-09-22 2002-06-14 Merck & Co Inc Antagonistas de receptores de taquiquinina zwitterionica
US6906085B2 (en) 2001-01-17 2005-06-14 Merck Sharp & Dohme Ltd. Tetrahydropyran derivatives as neurokinin receptor antagonists
GB0121874D0 (en) 2001-09-10 2001-10-31 Merck Sharp & Dohme Therapeutic agents
GB0217068D0 (en) * 2002-07-23 2002-08-28 Merck Sharp & Dohme Therapeutic agents
WO2004037843A2 (en) * 2002-10-25 2004-05-06 Yissum Research Development Company Of The Hebrew University Of Jerusalem Steroid compounds comprising superoxide dismutase mimic groups and nitric oxide donor groups, and their use in the preparation of medicaments
US20060166894A1 (en) * 2002-11-29 2006-07-27 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ace-inhibitors having antioxidant and no-donor activity
AU2004218228A1 (en) * 2003-03-07 2004-09-16 Merck Sharp & Dohme Limited Tetrahydropyran compounds as tachykinin antagonists
WO2006027345A2 (en) 2004-09-08 2006-03-16 Altana Pharma Ag Novel 3-thia-10-aza-phenanthrene derivatives
AU2005310229A1 (en) * 2004-11-30 2006-06-08 Mallinckrodt Inc. Crystallization method for benzphetamine
RU2382781C2 (ru) * 2005-04-22 2010-02-27 Дайити Санкио Компани, Лимитед Гетероциклическое соединение
CN100395242C (zh) * 2006-06-08 2008-06-18 华东理工大学 烷氧基萘和萘醌类吡喃碳糖苷化合物及其制备方法
DE102007010077B4 (de) * 2007-02-28 2010-04-08 RUHR-UNIVERSITäT BOCHUM [1,3]-Dioxane zur Modulation von GABAa-Rezeptoren
WO2013004766A1 (en) 2011-07-04 2013-01-10 Ferrari Giulio Nk-1 receptor antagonists for treating corneal neovascularisation
WO2014039504A1 (en) * 2012-09-04 2014-03-13 Lauren Sciences Llc Bolaamphiphilic compounds, compositions and uses thereof
JP2017525753A (ja) 2014-06-06 2017-09-07 フレクサス・バイオサイエンシーズ・インコーポレイテッドFlexus Biosciences, Inc. 免疫調節剤
UY36390A (es) 2014-11-05 2016-06-01 Flexus Biosciences Inc Compuestos moduladores de la enzima indolamina 2,3-dioxigenasa (ido), sus métodos de síntesis y composiciones farmacéuticas que los contienen
US11242319B2 (en) 2014-11-05 2022-02-08 Flexus Biosciences, Inc. Immunoregulatory agents
AR102537A1 (es) 2014-11-05 2017-03-08 Flexus Biosciences Inc Agentes inmunomoduladores
HU231150B1 (hu) 2017-03-13 2021-03-29 Richter Gedeon Nyrt Eljárás racém 3-alkilpiperidin-3-karbonsav-etil-észterek optikai izomerjeinek elválasztására
US11440896B2 (en) * 2018-02-06 2022-09-13 Daiichi Sankyo Company, Limited Aminoalkyl compound
EP4371613A3 (en) 2018-02-26 2024-07-24 Ospedale San Raffaele S.r.l. Compounds for use in the treatment of ocular pain
EP4117673A1 (en) 2020-03-11 2023-01-18 Ospedale San Raffaele S.r.l. Treatment of stem cell deficiency

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9301920D0 (en) * 1993-02-01 1993-03-17 Foundation For Ethnobiology Th Polycetylenes

Also Published As

Publication number Publication date
PE20001556A1 (es) 2001-01-13
AU3304200A (en) 2000-10-09
CZ20013377A3 (cs) 2002-02-13
EE200100491A (et) 2002-12-16
DE60004504T2 (de) 2004-06-24
DE60004504D1 (de) 2003-09-18
IL144236A0 (en) 2002-05-23
ES2203434T3 (es) 2004-04-16
AU746251B2 (en) 2002-04-18
SK13322001A3 (sk) 2002-02-05
CO5150225A1 (es) 2002-04-29
WO2000056728A1 (en) 2000-09-28
CA2367985A1 (en) 2000-09-28
WO2000056727A1 (en) 2000-09-28
HUP0200441A2 (hu) 2002-07-29
AU3304400A (en) 2000-10-09
NO20014529L (no) 2001-11-13
EA200100902A1 (ru) 2002-02-28
US6458830B1 (en) 2002-10-01
HUP0200441A3 (en) 2002-09-30
BR0009127A (pt) 2001-12-26
KR20010113773A (ko) 2001-12-28
CN1344264A (zh) 2002-04-10
PL350123A1 (en) 2002-11-04
EP1165540B1 (en) 2003-08-13
JP2002540107A (ja) 2002-11-26
ATE247096T1 (de) 2003-08-15
BG105859A (bg) 2002-04-30
EP1165540A1 (en) 2002-01-02

Similar Documents

Publication Publication Date Title
NO20014529D0 (no) Tetrahydropyranderivater og deres anvendelse som terapautiske midler
ATE360631T1 (de) Azabicyclische heterocyclen als modulatoren des cannabinoidrezeptors
DE602004006165D1 (de) Azabicyclische heterocyclen als modulatoren des cannabinoidrezeptors
TR200201505T2 (tr) Terapötik maddeler olarak pirazolopirimidinler
AU2003301020A8 (en) Isoquinolinone derivatives and their use as therapeutic agents
UY27368A1 (es) Nuevos compuestos
BR0113838A (pt) Derivados de n-fenil-2-pirimidina-amina
NO20054905L (no) 2-acylamino-4-fenyltiazolderivater, fremgangsmate for deres fremstilling og anvendelse av de samme som i terapeutika
SE0101387D0 (sv) Novel compounds
AU5650901A (en) Cyclohexane derivatives and their use as therapeutic agents
NO985977L (no) Spiro-piperidinderivater og deres anvendelse som terapeutiske midler
NO20050851L (no) Kaspase-inhibitorer og anvendelser derav
NO990433L (no) Nye forbindelser og blandinger for behandling av sykdommer i forbindelse med tryptase-aktivitet
SE9900961D0 (sv) Novel compounds
NO20055977L (no) Nye benzimidazolderivater
DK1483251T3 (da) C3-cyano-epothilon-derivater
ATE368040T1 (de) Substituierte tetrazyklische pyprolochinolonderivate als phosphodiesterase- inhibitoren
NO20033959D0 (no) Benzimidazoler som er nyttige i behandling av seksuell dysfunksjon
SE0301320D0 (sv) Positive modulators of nicotinic acetylcholine receptors
DE60013486D1 (de) Verbindungen
GEP20053590B (en) Phenyl Heterocyclyl Ether Derivatives as Serotonin Re-Uptake Inhibitors
JO2231B1 (en) Derivatives of Trahydroperan and its use as a therapeutic agent
MXPA06007007A (es) Derivados de prolina usados como ingredientes farmaceuticos activos para el tratamiento de tumores.
ES2163730T3 (es) Derivados espirocetales y su uso como agentes terapeuticos.
BR0313000A (pt) Compostos, composição farmacêutica e método para efetuar a inibição da enzima pde4, realçar a cognição e/ou tratar a psicose em um paciente

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application